- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 20, 2025 | 80.88M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $312 |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $27.21K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $337.96K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $307.93K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $337.96K |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $307.93K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $71.27K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $123.83K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $360.11K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $415.57K |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 78.76M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $609 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$100.82K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $140.78K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$76.44K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $92.98K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$479.35K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$485.88K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $10.57K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $29.84K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $23.69K |